Dr. Lambros Stamatakis

What to do when prostate cancer biopsy/PSA test results conflict

Ross Krasnow, MD, MPH, Urologic Oncologist, Lambros Stamatakis, MD, Director, Urologic Oncology September 28, 2017

Prostate cancer can be challenging to detect. Our screening and diagnostic tools—prostate-specific antigen (PSA) testing and transrectal ultrasound-guided (TRUS) prostate…

Treating bladder cancer: What patients need to know

Lambros Stamatakis, MD, Director, Urologic Oncology November 14, 2017

While bladder cancer doesn’t get as much press as colon or lung cancer, it’s the fourth-most common type of cancer…

Immunotherapy: The future course of bladder cancer care

Lambros Stamatakis, MD, Director, Urologic Oncology December 14, 2017

In the 1990s, the Food and Drug Administration (FDA) approved a treatment for bladder cancer called Bacillus Calmette-Guerin therapy, or…